269 related articles for article (PubMed ID: 28585053)
1. Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
Coulson J; Bagley L; Barnouin Y; Bradburn S; Butler-Browne G; Gapeyeva H; Hogrel JY; Maden-Wilkinson T; Maier AB; Meskers C; Murgatroyd C; Narici M; Pääsuke M; Sassano L; Sipilä S; Al-Shanti N; Stenroth L; Jones DA; McPhee JS
Osteoporos Int; 2017 Sep; 28(9):2683-2689. PubMed ID: 28585053
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.
Wanby P; Nobin R; Von SP; Brudin L; Carlsson M
J Endocrinol Invest; 2016 Aug; 39(8):855-63. PubMed ID: 26850415
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
Osteoporos Int; 2017 Mar; 28(3):945-953. PubMed ID: 27766367
[TBL] [Abstract][Full Text] [Related]
4. Association between osteocalcin and cognitive performance in healthy older adults.
Bradburn S; McPhee JS; Bagley L; Sipila S; Stenroth L; Narici MV; Pääsuke M; Gapeyeva H; Osborne G; Sassano L; Meskers CG; Maier AB; Hogrel JY; Barnouin Y; Butler-Browne G; Murgatroyd C
Age Ageing; 2016 Nov; 45(6):844-849. PubMed ID: 27515675
[TBL] [Abstract][Full Text] [Related]
5. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
[TBL] [Abstract][Full Text] [Related]
6. Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis.
Brabnikova-Maresova K; Jarosova K; Pavelka K; Stepan JJ
Arthritis Res Ther; 2014 Oct; 16(5):460. PubMed ID: 25280749
[TBL] [Abstract][Full Text] [Related]
7. Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.
Kashii M; Matuso Y; Sugiura T; Fujimori T; Nagamoto Y; Makino T; Kaito T; Ebina K; Iwasaki M; Yoshikawa H
J Bone Miner Metab; 2016 May; 34(3):315-24. PubMed ID: 26040409
[TBL] [Abstract][Full Text] [Related]
8. Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women.
Lim Y; Kim CH; Lee SY; Kim H; Ahn SH; Lee SH; Koh JM; Rhee Y; Baek KH; Min YK; Kim DY; Kim BJ; Kang MI
Calcif Tissue Int; 2016 Oct; 99(4):350-9. PubMed ID: 27289555
[TBL] [Abstract][Full Text] [Related]
9. Circulating sclerostin associated with vertebral bone marrow fat in older men but not women.
Ma YH; Schwartz AV; Sigurdsson S; Hue TF; Lang TF; Harris TB; Rosen CJ; Vittinghoff E; Eiriksdottir G; Hauksdottir AM; Siggeirsdottir K; Sigurdsson G; Oskarsdottir D; Napoli N; Palermo L; Gudnason V; Li X
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2584-90. PubMed ID: 25144629
[TBL] [Abstract][Full Text] [Related]
10. Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients.
Vigil FMB; Vaz de Castro PAS; Hasparyk UG; Bartolomei VS; Simões E Silva AC
Curr Med Chem; 2024; 31(19):2809-2820. PubMed ID: 38332694
[TBL] [Abstract][Full Text] [Related]
11. Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer.
Kyvernitakis I; Rachner TD; Urbschat A; Hars O; Hofbauer LC; Hadji P
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1671-80. PubMed ID: 24903965
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.
Taylan A; Sari I; Akinci B; Bilge S; Kozaci D; Akar S; Colak A; Yalcin H; Gunay N; Akkoc N
BMC Musculoskelet Disord; 2012 Oct; 13():191. PubMed ID: 23025387
[TBL] [Abstract][Full Text] [Related]
13. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
[TBL] [Abstract][Full Text] [Related]
14. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
Wang N; Xue P; Wu X; Ma J; Wang Y; Li Y
Endocr Res; 2018 Feb; 43(1):29-38. PubMed ID: 28972408
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin and Pref-1 have differential effects on bone mineral density and strength parameters in adolescent athletes compared with non-athletes.
Fazeli PK; Ackerman KE; Pierce L; Guereca G; Bouxsein M; Misra M
Osteoporos Int; 2013 Sep; 24(9):2433-40. PubMed ID: 23579340
[TBL] [Abstract][Full Text] [Related]
16. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.
Terpos E; Fragiadaki K; Konsta M; Bratengeier C; Papatheodorou A; Sfikakis PP
Clin Exp Rheumatol; 2011; 29(6):921-5. PubMed ID: 22032557
[TBL] [Abstract][Full Text] [Related]
17. Alterations in bone turnover markers in patients with noncardio-embolic ischemic stroke.
Mathold K; Wanby P; Brudin L; Von SP; Carlsson M
PLoS One; 2018; 13(11):e0207348. PubMed ID: 30496210
[TBL] [Abstract][Full Text] [Related]
18. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.
Hsu BG; Liou HH; Lee CJ; Chen YC; Ho GJ; Lee MC
Medicine (Baltimore); 2016 Apr; 95(15):e3300. PubMed ID: 27082570
[TBL] [Abstract][Full Text] [Related]
19. Sclerostin: a candidate biomarker of SCI-induced osteoporosis.
Morse LR; Sudhakar S; Lazzari AA; Tun C; Garshick E; Zafonte R; Battaglino RA
Osteoporos Int; 2013 Mar; 24(3):961-8. PubMed ID: 22801952
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
